279 related articles for article (PubMed ID: 11753612)
1. Molecular characterization of genomic AML1-ETO fusions in childhood leukemia.
Xiao Z; Greaves MF; Buffler P; Smith MT; Segal MR; Dicks BM; Wiencke JK; Wiemels JL
Leukemia; 2001 Dec; 15(12):1906-13. PubMed ID: 11753612
[TBL] [Abstract][Full Text] [Related]
2. Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.
Zhang Y; Strissel P; Strick R; Chen J; Nucifora G; Le Beau MM; Larson RA; Rowley JD
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3070-5. PubMed ID: 11867721
[TBL] [Abstract][Full Text] [Related]
3. Chromatin structural elements and chromosomal translocations in leukemia.
Zhang Y; Rowley JD
DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
[TBL] [Abstract][Full Text] [Related]
4. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.
Kozu T; Miyoshi H; Shimizu K; Maseki N; Kaneko Y; Asou H; Kamada N; Ohki M
Blood; 1993 Aug; 82(4):1270-6. PubMed ID: 8353289
[TBL] [Abstract][Full Text] [Related]
5. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia.
Wiemels JL; Xiao Z; Buffler PA; Maia AT; Ma X; Dicks BM; Smith MT; Zhang L; Feusner J; Wiencke J; Pritchard-Jones K; Kempski H; Greaves M
Blood; 2002 May; 99(10):3801-5. PubMed ID: 11986239
[TBL] [Abstract][Full Text] [Related]
6. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.
Higuchi M; O'Brien D; Kumaravelu P; Lenny N; Yeoh EJ; Downing JR
Cancer Cell; 2002 Feb; 1(1):63-74. PubMed ID: 12086889
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of novel AML1-ETO fusion transcripts in pediatric t(8;21) acute myeloid leukemia: a report from the Children's Oncology Group.
LaFiura KM; Edwards H; Taub JW; Matherly LH; Fontana JA; Mohamed AN; Ravindranath Y; Ge Y;
Oncogene; 2008 Aug; 27(36):4933-42. PubMed ID: 18469864
[TBL] [Abstract][Full Text] [Related]
8. Microclustering of TEL-AML1 translocation breakpoints in childhood acute lymphoblastic leukemia.
Wiemels JL; Alexander FE; Cazzaniga G; Biondi A; Mayer SP; Greaves M
Genes Chromosomes Cancer; 2000 Nov; 29(3):219-28. PubMed ID: 10992297
[TBL] [Abstract][Full Text] [Related]
9. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.
de Greef GE; Hagemeijer A; Morgan R; Wijsman J; Hoefsloot LH; Sandberg AA; Sacchi N
Leukemia; 1995 Feb; 9(2):282-7. PubMed ID: 7869765
[TBL] [Abstract][Full Text] [Related]
10. Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21).
Kwong YL; Chan V; Wong KF; Chan TK
Cancer; 1995 Feb; 75(3):821-5. PubMed ID: 7828132
[TBL] [Abstract][Full Text] [Related]
11. Specific protein redirection as a transcriptional therapy approach for t(8;21) leukemia.
Steffen B; Serve H; Berdel WE; Agrawal S; Linggi B; Büchner T; Hiebert SW; Müller-Tidow C
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8448-53. PubMed ID: 12819347
[TBL] [Abstract][Full Text] [Related]
12. AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia.
Dunne J; Gascoyne DM; Lister TA; Brady HJ; Heidenreich O; Young BD
Cancer Res; 2010 May; 70(10):3985-95. PubMed ID: 20460523
[TBL] [Abstract][Full Text] [Related]
13. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
14. The AML1 and ETO genes in acute myeloid leukemia with a t(8;21).
Nucifora G; Rowley JD
Leuk Lymphoma; 1994 Aug; 14(5-6):353-62. PubMed ID: 7812194
[TBL] [Abstract][Full Text] [Related]
15. The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.
Bakshi R; Zaidi SK; Pande S; Hassan MQ; Young DW; Montecino M; Lian JB; van Wijnen AJ; Stein JL; Stein GS
J Cell Sci; 2008 Dec; 121(Pt 23):3981-90. PubMed ID: 19001502
[TBL] [Abstract][Full Text] [Related]
16. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
Erickson PF; Dessev G; Lasher RS; Philips G; Robinson M; Drabkin HA
Blood; 1996 Sep; 88(5):1813-23. PubMed ID: 8781439
[TBL] [Abstract][Full Text] [Related]
17. The ETO domain is necessary for the developmental abnormalities associated with AML1-ETO expression in the hematopoietic stem cell compartment in vivo.
de Guzman CG; Johnson A; Klug CA
Blood Cells Mol Dis; 2003; 30(2):201-6. PubMed ID: 12732184
[TBL] [Abstract][Full Text] [Related]
18. The AML1/ETO fusion protein activates transcription of BCL-2.
Klampfer L; Zhang J; Zelenetz AO; Uchida H; Nimer SD
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14059-64. PubMed ID: 8943060
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic consequences of AML1-ETO action at the human c-FMS locus.
Follows GA; Tagoh H; Lefevre P; Hodge D; Morgan GJ; Bonifer C
EMBO J; 2003 Jun; 22(11):2798-809. PubMed ID: 12773394
[TBL] [Abstract][Full Text] [Related]
20. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells.
Zaidi SK; Perez AW; White ES; Lian JB; Stein JL; Stein GS
Oncotarget; 2017 Jun; 8(25):39994-40005. PubMed ID: 28611288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
